Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Frequency Therapeutics, Inc. (FREQ)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Jun-05-23 | Dec-31-22 | Dec-05-22 | Sep-30-22 | Sep-05-22 | Jun-30-22 | Jun-05-22 |
| 10-Q | 8-K | 10-K | 8-K | 10-Q | 8-K | 10-Q | 8-K |
Revenues | | 100.0% | | 100.0% | 100.0% | 100.0% | | 100.0% |
Cost of goods sold | | 257.5% | | 170.9% | 0.0% | 173.1% | | 160.3% |
Gross profit | | -157.5% | | -70.9% | 100.0% | -73.1% | | -60.3% |
Selling, general and administrative | | | | | 2027500.0% | | | |
Research and development | | | | | | | | |
General and administrative | | 157.5% | | 70.9% | | 73.1% | | 60.3% |
EBITDA | | -257.5% | | -170.9% | -1959500.0% | -173.1% | | -160.3% |
Depreciation | | | | | 67900.0% | | | |
EBIT | | -257.5% | | -170.9% | -2027400.0% | -173.1% | | -160.3% |
Pre-tax income | | -234.9% | | -163.0% | -1957000.0% | -167.1% | | -160.3% |
Income taxes | | 0.1% | | 0.1% | -2300.0% | -0.2% | | 0.0% |
Net income | | -235.0% | | -163.0% | -1954700.0% | -166.9% | | -160.4% |
|